Shanghai Sanyou Medical Co., Ltd (SHA:688085)

Market Cap	6.38B +32.2%
Revenue (ttm)	542.79M +19.7%
Net Income	63.29M +451.8%
EPS	0.19 +355.6%
Shares Out	333.46M
PE Ratio	100.68
Forward PE	50.34
Dividend	0.00 (0.02%)
Ex-Dividend Date	Jul 17, 2025

Volume	3,103,422
Average Volume	2,678,421
Open	18.93
Previous Close	18.63
Day's Range	18.70 - 19.17
52-Week Range	12.84 - 26.13
Beta	-0.01
RSI	44.40
Earnings Date	Apr 28, 2026

About Shanghai Sanyou Medical

Shanghai Sanyou Medical Co., Ltd. researches, develops, manufactures, and sells orthopedics implants in China. The company offers spinal and trauma implants under Tytus and Sanyou brand. Its spinal products comprise anterior cervical plate, anterior thoracolumbar, posterior cervical, posterior thoracolumbar, and minimally invasive products; and trauma implants, including shoulder and elbow system, hip and pelvis system, knee joint system, foot and ankle, and palm and wrist systems. It also offers sports medicine. Shanghai Sanyou Medical Co., Lt...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 514
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688085

Financial Performance

In 2025, Shanghai Sanyou Medical's revenue was 542.79 million, an increase of 19.66% compared to the previous year's 453.60 million. Earnings were 63.29 million, an increase of 451.85%.